Identification | Back Directory | [Name]
Hydrazinecarbothioamide, 2-[(2-hydroxy-5-methylphenyl)methylene]-N-(3-methoxyphenyl)- | [CAS]
2799695-54-6 | [Synonyms]
Hydrazinecarbothioamide, 2-[(2-hydroxy-5-methylphenyl)methylene]-N-(3-methoxyphenyl)- | [Molecular Formula]
C16H17N3O2S | [MOL File]
2799695-54-6.mol | [Molecular Weight]
315.39 |
Chemical Properties | Back Directory | [Boiling point ]
476.4±55.0 °C(Predicted) | [density ]
1.22±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
8.25±0.48(Predicted) | [color ]
White to off-white |
Hazard Information | Back Directory | [Uses]
ALR2-IN-1 is a potent and selective ALR2 inhibitor (IC50=1.42 μM). ALR2-IN-1 shows antioxidant and antiglycative properties. ALR2-IN-1 can be used in diabetic complication research[1]. | [References]
[1] Aqeel Imran, et al. Development, Molecular Docking, and In Silico ADME Evaluation of Selective ALR2 Inhibitors for the Treatment of Diabetic Complications via Suppression of the Polyol Pathway. ACS Omega 2022. |
|
|